Gnosis is glad to inform that Adonat® WhitePaper, which is dedicated to the Gnosis commercially stable form of S-Adenosyl-L-methionine (SAMe), has been recently implemented with new contents and with updated results from the latest clinical studies.
The great importance of the One Carbon Metabolism, crucial for people overall health and well-being, has always led researchers to be particularly interested in discovering how the availability and levels of molecules involved into this metabolic pathway can influence and affect human health, with particular emphasis on SAMe, the most important human methyl donor, capable to sustain the above cycle activity.
Adonatis involved in more than one hundred biochemical pathways and is important for a variety of functions including detoxification, energy production, immune function, gene maintenance and regulation, mood balancing and inflammation control.
In the new Adonat white paper, besides the well-known and most studied fields of application of SAMe ranging from the mood enhancement to the liver protection and detoxification, new clinical evidence suggests its wider involvement in preventing aging and supporting cell and organ longevity, including also brain as well as sexual functions and cellular metabolism.
Gnosis has been the first to introduce and commercialise SAMe in the worldwide market and, with over 30 years of experience, today is considered the global leader in SAMe manufacturing from a selected highly productive yeast using fermentation technologies, under the brand name of Adonat, with a complete range of bulk powder, enteric coated tablets and stabilised oral dosage forms for pharmaceutical, nutritional and veterinary applications.
Adonat has excellent features:
If you want to learn more about Adonat® and all benefits associated with its assumption, ask for a copy of the newly restyled white paper at www.gnosis-bio.com/AdonatWhitePaper.